{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:11:32Z","timestamp":1772809892764,"version":"3.50.1"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Microbial Sciences"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.crmicr.2024.100323","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T12:14:05Z","timestamp":1732277645000},"page":"100323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Advancing cryptococcal treatment: The role of nanoparticles in mitigating antifungal resistance"],"prefix":"10.1016","volume":"8","author":[{"given":"Rahul Harikumar","family":"Lathakumari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leela Kakithakara","family":"Vajravelu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Satheesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayaprakash","family":"Thulukanam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.crmicr.2024.100323_bib0001","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1128\/AAC.48.3.985-991.2004","article-title":"Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis","volume":"48","author":"A","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.crmicr.2024.100323_bib0002","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11051-023-05690-w","article-title":"Structural parameters of nanoparticles affecting their toxicity for biomedical applications: a review","volume":"25","author":"Abbasi","year":"2023","journal-title":"J. Nanopart. Res."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100323_bib0003","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s11671-023-03852-2","article-title":"Carboxymethyl cellulose\/sulfur-functionalized Ti-based MOF composite: synthesis, characterization, antimicrobial, antiviral and anticancer potentiality","volume":"18","author":"Abdelhameed","year":"2023","journal-title":"Discover. Nano"},{"issue":"7","key":"10.1016\/j.crmicr.2024.100323_bib0004","first-page":"1167","article-title":"Solid lipid nanoparticles, an effective carrier for classical antifungal drugs","volume":"31","author":"Almawash","year":"2023","journal-title":"Saudi Pharm. J. SPJ Offic. Publ. Saudi Pharm. Soc."},{"issue":"6","key":"10.1016\/j.crmicr.2024.100323_bib0006","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s15010-017-1042-z","article-title":"Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients","volume":"45","author":"Bellmann","year":"2017","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.crmicr.2024.100323_bib0007","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41467-019-13890-z","article-title":"5-fluorocytosine resistance is associated with hypermutation and alterations in capsule biosynthesis in Cryptococcus","volume":"11","author":"Billmyre","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100323_bib0008","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41467-019-13890-z","article-title":"5-fluorocytosine resistance is associated with hypermutation and alterations in capsule biosynthesis in Cryptococcus","volume":"11","author":"Billmyre","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.crmicr.2024.100323_bib0009","doi-asserted-by":"crossref","DOI":"10.1007\/s10123-024-00504-y","article-title":"Exposure of Cryptococcus neoformans to low nitrogen levels enhances virulence","author":"Bosch","year":"2024","journal-title":"Int. Microbiol."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100323_bib0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/mmy\/myz018","article-title":"Effect of non-antifungal agrochemicals on the pathogenic fungus Cryptococcus gattii","volume":"58","author":"Carneiro","year":"2020","journal-title":"Med. Mycol."},{"key":"10.1016\/j.crmicr.2024.100323_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00855","article-title":"Mechanisms of cryptococcus neoformans-mediated host damage","volume":"9","author":"Casadevall","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100323_bib0012","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40121-020-00382-7","article-title":"Sixty years of amphotericin b: an overview of the main antifungal agent used to treat invasive fungal infections","volume":"10","author":"Cavassin","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.crmicr.2024.100323_bib0013","doi-asserted-by":"crossref","unstructured":"Chandra, J., Mohammad, S., & Ghannoum, M.A. (2009). Flucytosine: Site of Action, Mechanism of Resistance and Use in Combination Therapy BT - Antimicrobial Drug Resistance: Mechanisms of Drug Resistance (D. L. Mayers, Ed.; pp. 313\u2013326). Humana Press. https:\/\/doi.org\/10.1007\/978-1-59745-180-2_27.","DOI":"10.1007\/978-1-59745-180-2_27"},{"issue":"11","key":"10.1016\/j.crmicr.2024.100323_bib0014","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/mmy\/myab042","article-title":"Complexing amphotericin B with gold nanoparticles improves fungal clearance from the brains of mice infected with Cryptococcal neoformans","volume":"59","author":"Chintalacharuvu","year":"2021","journal-title":"Med. Mycol."},{"key":"10.1016\/j.crmicr.2024.100323_bib0015","doi-asserted-by":"crossref","unstructured":"Dambuza, I.M., Drake, T., Chapuis, A., Zhou, X., Correia, J., Taylor-smith, L., Legrave, N., Rasmussen, T., Fisher, M.C., Bicanic, T., Harrison, T.S., Jaspars, M., May, R.C., Brown, D., Yuecel, R., Maccallum, D.M., & Ballou, E.R. (2018). The Cryptococcus neoformans Titan cell is an inducible and regulated morphotype underlying pathogenesis. 1\u201328.","DOI":"10.1101\/190587"},{"issue":"11","key":"10.1016\/j.crmicr.2024.100323_bib0016","article-title":"Molecular mechanisms of 5-fluorocytosine resistance in yeasts and filamentous fungi","volume":"7","author":"Delma","year":"2021","journal-title":"J. Fungi (Basel, Switzerland)"},{"key":"10.1016\/j.crmicr.2024.100323_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.634286","article-title":"The A756T mutation of the ERG11 gene associated with resistance to itraconazole in candida krusei isolated from mycotic mastitis of cows","volume":"8","author":"Du","year":"2021","journal-title":"Front. Vet. Sci."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100323_bib0018","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/21505594.2020.1772657","article-title":"Titan cell formation is unique to Cryptococcus species complex","volume":"11","author":"Dyl\u0105g","year":"2020","journal-title":"Virulence"},{"issue":"12","key":"10.1016\/j.crmicr.2024.100323_bib0019","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11274-022-03425-y","article-title":"Antifungal and antibiofilm activities of bee venom loaded on chitosan nanoparticles: a novel approach for combating fungal human pathogens","volume":"38","author":"El-Didamony","year":"2022","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.crmicr.2024.100323_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.00048","article-title":"The design of poly(lactide-co-glycolide) nanocarriers for medical applications","volume":"8","author":"Essa","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"7","key":"10.1016\/j.crmicr.2024.100323_bib0021","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s13738-023-02790-1","article-title":"Synthesis, antimicrobial activity, theoretical investigation, and electrochemical studies of cellulosic metal complexes","volume":"20","author":"Fahim","year":"2023","journal-title":"J. Iran. Chem. Soc."},{"issue":"3","key":"10.1016\/j.crmicr.2024.100323_bib0022","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12291-013-0364-6","article-title":"Polybutylcyanoacrylate nanoparticles and drugs of the platinum family: last status","volume":"29","author":"Fatemeh","year":"2014","journal-title":"Indian J. Clin. Biochem. IJCB"},{"issue":"2","key":"10.1016\/j.crmicr.2024.100323_bib0023","first-page":"e00723","article-title":"Adaptation to fluconazole via aneuploidy enables cross-adaptation to amphotericin B and flucytosine in cryptococcus neoformans","volume":"9","author":"Feng","year":"2021","journal-title":"Microbiol. Spectr."},{"issue":"9","key":"10.1016\/j.crmicr.2024.100323_bib0024","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41579-022-00720-1","article-title":"Tackling the emerging threat of antifungal resistance to human health","volume":"20","author":"Fisher","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"issue":"6","key":"10.1016\/j.crmicr.2024.100323_bib0025","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00729-19","article-title":"Nanoemulsion as an effective treatment against human-pathogenic fungi","volume":"4","author":"Garcia","year":"2019","journal-title":"MSphere"},{"key":"10.1016\/j.crmicr.2024.100323_bib0026","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/NSA.S96018","article-title":"Synthesis, characterization, and in vitro activity against Candida spp. of fluconazole encapsulated on cationic and conventional nanoparticles of poly(lactic-co-glycolic acid)","volume":"10","author":"G\u00f3mez-Sequeda","year":"2017","journal-title":"Nanotechnol. Sci. Appl."},{"issue":"2","key":"10.1016\/j.crmicr.2024.100323_bib0027","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/JOC.JOC_110_18","article-title":"DNA extraction and polymerase chain reaction","volume":"36","author":"Gupta","year":"2019","journal-title":"J. Cytol."},{"issue":"2","key":"10.1016\/j.crmicr.2024.100323_bib0028","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.glohj.2023.02.008","article-title":"Applications of nanotechnology in medical field: a brief review","volume":"7","author":"Haleem","year":"2023","journal-title":"Glob. Health J."},{"key":"10.1016\/j.crmicr.2024.100323_bib0029","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.ijbiomac.2019.04.024","article-title":"Nano-amino acid cellulose derivatives: eco-synthesis, characterization, and antimicrobial properties","volume":"132","author":"Hasanin","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"6","key":"10.1016\/j.crmicr.2024.100323_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11061380","article-title":"Biosynthesis, characterization, and antifungal activity of novel trimetallic copper oxide\u2013selenium\u2013zinc oxide nanoparticles against some mucorales fungi","volume":"11","author":"Hashem","year":"2023","journal-title":"Microorganisms"},{"issue":"33","key":"10.1016\/j.crmicr.2024.100323_bib0031","doi-asserted-by":"crossref","first-page":"22918","DOI":"10.1039\/D3RA03260D","article-title":"Sustainable biosynthesized bimetallic ZnO@SeO nanoparticles from pomegranate peel extracts: antibacterial, antifungal and anticancer activities","volume":"13","author":"Hashem","year":"2023","journal-title":"RSC Adv."},{"issue":"3","key":"10.1016\/j.crmicr.2024.100323_bib0032","doi-asserted-by":"crossref","DOI":"10.3390\/jfb13030112","article-title":"Unveiling antimicrobial and insecticidal activities of biosynthesized selenium nanoparticles using prickly pear peel waste","volume":"13","author":"Hashem","year":"2022","journal-title":"J. Funct. Biomater."},{"issue":"19","key":"10.1016\/j.crmicr.2024.100323_bib0033","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1016\/j.cub.2023.08.054","article-title":"Distinct pathways of adaptive evolution in Cryptococcus neoformans reveal a mutation in adenylyl cyclase with trade-offs for pathogenicity","volume":"33","author":"Hilbert","year":"2023","journal-title":"Curr. Biol."},{"issue":"7","key":"10.1016\/j.crmicr.2024.100323_bib0034","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12070604","article-title":"Protein-based nanoparticles as drug delivery systems","volume":"12","author":"Hong","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.crmicr.2024.100323_bib0035","doi-asserted-by":"crossref","first-page":"12480","DOI":"10.1038\/s41598-020-68978-0","article-title":"A novel method for identifying and distinguishing Cryptococcus neoformans and Cryptococcus gattii by surface-enhanced Raman scattering using positively charged silver nanoparticles","volume":"10","author":"Hu","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100323_bib0036","doi-asserted-by":"crossref","first-page":"10421","DOI":"10.1038\/s41598-017-09636-w","article-title":"ROS-induced oxidative injury involved in pathogenesis of fungal keratitis via p38 MAPK activation","volume":"7","author":"Hua","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.crmicr.2024.100323_bib0037","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.addr.2020.09.009","article-title":"Polymeric micelles for the delivery of poorly soluble drugs: from nanoformulation to clinical approval","volume":"156","author":"Hwang","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100323_bib0038","first-page":"e02549","article-title":"Accumulation of endogenous free radicals is required to induce titan-like cell formation in Cryptococcus neoformans","volume":"15","author":"Irene","year":"2023","journal-title":"MBio"},{"issue":"2","key":"10.1016\/j.crmicr.2024.100323_bib0039","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1590\/0074-0276130269","article-title":"Silver nanoparticle production by the fungus Fusarium oxysporum: nanoparticle characterisation and analysis of antifungal activity against pathogenic yeasts","volume":"109","author":"Ishida","year":"2014","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"7","key":"10.1016\/j.crmicr.2024.100323_bib0040","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41579-021-00511-0","article-title":"Treatment strategies for cryptococcal infection: challenges, advances and future outlook","volume":"19","author":"Iyer","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.crmicr.2024.100323_bib0041","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/ciy515","article-title":"Short-course High-dose liposomal amphotericin B for human immunodeficiency virus\u2013associated cryptococcal meningitis: a phase 2 randomized controlled trial","volume":"68","author":"Jarvis","year":"2019","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.crmicr.2024.100323_bib0042","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/ciy515","article-title":"Short-course high-dose liposomal amphotericin B for human immunodeficiency virus\u2013associated cryptococcal meningitis: a phase 2 randomized controlled trial","volume":"68","author":"Jarvis","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.crmicr.2024.100323_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00610","article-title":"Antifungal activity of chitosan nanoparticles encapsulated with cymbopogon martinii essential oil on plant pathogenic fungi fusarium graminearum","volume":"9","author":"Kalagatur","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.crmicr.2024.100323_bib0044","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.chom.2023.12.012","article-title":"Fungicide-tolerant persister formation during cryptococcal pulmonary infection","volume":"32","author":"Ke","year":"2024","journal-title":"Cell Host Microbe"},{"issue":"8","key":"10.1016\/j.crmicr.2024.100323_bib0045","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1007\/s12010-023-04407-y","article-title":"Green synthesis of silver nanoparticles using salvadora persica and caccinia macranthera extracts: cytotoxicity analysis and antimicrobial activity against antibiotic-resistant bacteria","volume":"195","author":"Khojasteh-Taheri","year":"2023","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.crmicr.2024.100323_bib0046","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.00463","article-title":"Therapies and vaccines based on nanoparticles for the treatment of systemic fungal infections","volume":"10","author":"Kischkel","year":"2020","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100323_bib0047","doi-asserted-by":"crossref","first-page":"70","DOI":"10.7150\/ntno.77395","article-title":"A systemic review on development of mesoporous nanoparticles as a vehicle for transdermal drug delivery","volume":"7","author":"Kolimi","year":"2023","journal-title":"Nanotheranostics"},{"key":"10.1016\/j.crmicr.2024.100323_bib0048","doi-asserted-by":"crossref","DOI":"10.7860\/JCDR\/2022\/58018.17065","article-title":"Efficacy of green synthesised iron oxide nanoparticles against various uropathogens: a cross-sectional study","author":"Lathakumari","year":"2022","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.crmicr.2024.100323_bib0049","article-title":"Antibiotics and the gut microbiome: understanding the impact on human health","volume":"20","author":"Lathakumari","year":"2024"},{"issue":"2","key":"10.1016\/j.crmicr.2024.100323_bib0050","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1099\/mic.0.000589","article-title":"A novel mechanism of fluconazole: fungicidal activity through dose-dependent apoptotic responses in Candida albicans","volume":"164","author":"Lee","year":"2018","journal-title":"Microbiology (Reading, Engl.)"},{"issue":"10","key":"10.1016\/j.crmicr.2024.100323_bib0051","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10101303","article-title":"Nanomaterial-based antifungal therapies to combat fungal diseases aspergillosis, coccidioidomycosis, mucormycosis, and candidiasis","volume":"10","author":"Le\u00f3n-Buitimea","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.crmicr.2024.100323_bib0052","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1074903","article-title":"Synergistic effect of pyrvinium pamoate and posaconazole against Cryptococcus neoformans in vitro and in vivo","volume":"12","author":"Li","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"7","key":"10.1016\/j.crmicr.2024.100323_bib0053","article-title":"The added value of longitudinal imaging for preclinical in vivo efficacy testing of therapeutic compounds against cerebral cryptococcosis","volume":"64","author":"Liesbeth","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.crmicr.2024.100323_bib0054","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41577-022-00826-w","article-title":"Immune responses to human fungal pathogens and therapeutic prospects","volume":"23","author":"Lionakis","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.crmicr.2024.100323_bib0055","first-page":"1","article-title":"Clinical treatment of cryptococcal meningitis: an evidence-based review on the emerging clinical data","author":"Liu","year":"2024","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100323_bib0056","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/cid\/cir745","article-title":"Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis","volume":"54","author":"Loyse","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.crmicr.2024.100323_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2023.101733","article-title":"A comprehensive review on potential applications of metallic nanoparticles as antifungal therapies to combat human fungal diseases","volume":"31","author":"Madkhali","year":"2023","journal-title":"Saudi Pharm. J."},{"issue":"3","key":"10.1016\/j.crmicr.2024.100323_bib0058","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1021\/acs.biomac.1c01248","article-title":"Isolation and characterization of chitosans from different fungi with special emphasis on zygomycetous dimorphic fungus benjaminiella poitrasii: evaluation of its chitosan nanoparticles for the inhibition of human pathogenic fungi","volume":"23","author":"Mane","year":"2022","journal-title":"Biomacromolecules"},{"issue":"4","key":"10.1016\/j.crmicr.2024.100323_bib0059","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12040371","article-title":"Endocytosis: the nanoparticle and submicron nanocompounds gateway into the cell","volume":"12","author":"Manzanares","year":"2020","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.crmicr.2024.100323_bib0060","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11071626","article-title":"Nanoemulsion increases the antifungal activity of amphotericin b against four candida auris clades: in vitro and in vivo assays","volume":"11","author":"Marena","year":"2023","journal-title":"Microorganisms"},{"issue":"4","key":"10.1016\/j.crmicr.2024.100323_bib0061","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.biomaterials.2009.09.087","article-title":"The use of chitosan to damage Cryptococcus neoformans biofilms","volume":"31","author":"Martinez","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.crmicr.2024.100323_bib0062","doi-asserted-by":"crossref","unstructured":"McClelland, E.E., Casadevall, A., & Eisenman, H.C. (2007). Pathogenesis of Cryptococcus neoformans BT - New Insights in Medical Mycology (K. Kavanagh, Ed.; pp. 131\u2013157). Springer Netherlands. https:\/\/doi.org\/10.1007\/978-1-4020-6397-8_6.","DOI":"10.1007\/978-1-4020-6397-8_6"},{"issue":"2","key":"10.1016\/j.crmicr.2024.100323_bib0063","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.crmicr.2024.100323_bib0064","first-page":"227","article-title":"Comparison of antifungal activities of zinc, copper, cerium oxide, silver, gold, and selenium nanoparticles against clinical isolates of Aspergillus","volume":"10","author":"Moghadam","year":"2023","journal-title":"Nanomed. J."},{"issue":"3","key":"10.1016\/j.crmicr.2024.100323_bib0065","doi-asserted-by":"crossref","first-page":"myac005","DOI":"10.1093\/mmy\/myac005","article-title":"Investigation of fluconazole heteroresistance in clinical and environmental isolates of Cryptococcus neoformans complex and Cryptococcus gattii complex in the state of Amazonas, Brazil","volume":"60","author":"Moreira","year":"2022","journal-title":"Med. Mycol."},{"key":"10.1016\/j.crmicr.2024.100323_bib0066","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.705886","article-title":"Liposomes: structure, biomedical applications, and stability parameters with emphasis on cholesterol","volume":"9","author":"Nakhaei","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.crmicr.2024.100323_bib0067","series-title":"Materials For Biomedical Engineering","first-page":"211","article-title":"Nanoparticles: synthesis and applications","author":"Nam","year":"2019"},{"issue":"2","key":"10.1016\/j.crmicr.2024.100323_bib0068","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s42770-020-00248-7","article-title":"Incorporation of 2-amino-thiophene derivative in nanoparticles: enhancement of antifungal activity","volume":"51","author":"Neves","year":"2020","journal-title":"Braz. J. Microbiol. [Publication of the Brazilian Society for Microbiology]"},{"key":"10.1016\/j.crmicr.2024.100323_bib0069","doi-asserted-by":"crossref","DOI":"10.12688\/wellcomeopenres.15010.1","article-title":"A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis","volume":"4","author":"Ngan","year":"2019","journal-title":"Wellcome Open Res."},{"issue":"2","key":"10.1016\/j.crmicr.2024.100323_bib0070","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/infdis\/jit164","article-title":"Pharmacodynamics of liposomal amphotericin B and flucytosine for cryptococcal meningoencephalitis: safe and effective regimens for immunocompromised patients","volume":"208","author":"O'Connor","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.crmicr.2024.100323_bib0071","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1128\/IAI.71.11.6155-6164.2003","article-title":"Induction of capsule growth in cryptococcus neoformans by mammalian serum and CO2","volume":"71","author":"Oscar","year":"2003","journal-title":"Infect. Immun."},{"issue":"0","key":"10.1016\/j.crmicr.2024.100323_bib0072","first-page":"e03902","article-title":"Host and fungal factors both contribute to cryptococcosis-associated hyperammonemia (cryptammonia)","volume":"0","author":"P","year":"2024","journal-title":"Microbiol. Spectr."},{"issue":"9","key":"10.1016\/j.crmicr.2024.100323_bib0073","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1128\/AAC.00229-16","article-title":"Isavuconazole is effective for the treatment of experimental cryptococcal meningitis","volume":"60","author":"P","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.crmicr.2024.100323_bib0074","first-page":"1","article-title":"Vomocytosis of Cryptococcus neoformans cells from murine, bone marrow-derived dendritic cells","author":"Pacifici","year":"2023","journal-title":"PLOS ONE"},{"issue":"7","key":"10.1016\/j.crmicr.2024.100323_bib0075","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2174\/1567201815666180409103028","article-title":"Preparation and in vitro evaluation of efficacy and toxicity of polysorbate 80-coated bovine serum albumin nanoparticles containing amphotericin B","volume":"15","author":"Pedroso","year":"2018","journal-title":"Curr. Drug Deliv."},{"issue":"4","key":"10.1016\/j.crmicr.2024.100323_bib0076","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1128\/AAC.29.4.579","article-title":"Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits","volume":"29","author":"Perfect","year":"1986","journal-title":"Antimicrob. Agents Chemother."},{"issue":"29","key":"10.1016\/j.crmicr.2024.100323_bib0077","doi-asserted-by":"crossref","first-page":"32845","DOI":"10.1021\/acsami.2c05165","article-title":"Application of fluconazole-loaded pH-sensitive lipid nanoparticles for enhanced antifungal therapy","volume":"14","author":"Rajesh","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"12","key":"10.1016\/j.crmicr.2024.100323_bib0078","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"1863","author":"Redza-Dutordoir","year":"2016","journal-title":"Biochimica et Biophysica Acta (BBA) - Molec. Cell Res."},{"issue":"2","key":"10.1016\/j.crmicr.2024.100323_bib0079","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1751-1097.2011.01055.x","article-title":"In vitro photodynamic inactivation of Cryptococcus neoformans melanized cells with chloroaluminum phthalocyanine nanoemulsion","volume":"88","author":"Rodrigues","year":"2012","journal-title":"Photochem. Photobiol."},{"issue":"4","key":"10.1016\/j.crmicr.2024.100323_bib0080","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1286-4579(99)80025-2","article-title":"Pathogenicity of Cryptococcus neoformans: virulence factors and immunological mechanisms","volume":"1","author":"Rodrigues","year":"1999","journal-title":"Microb. Infect."},{"issue":"3","key":"10.1016\/j.crmicr.2024.100323_bib0081","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12030196","article-title":"Development of amphotericin B micellar formulations based on copolymers of poly(ethylene glycol) and poly(\u03b5-caprolactone) conjugated with retinol","volume":"12","author":"Rodriguez","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.crmicr.2024.100323_bib0082","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2147\/IJN.S152010","article-title":"Biosynthesized silver and gold nanoparticles are potent antimycotics against opportunistic pathogenic yeasts and dermatophytes","volume":"13","author":"R\u00f3nav\u00e1ri","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.crmicr.2024.100323_bib0083","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2147\/IJN.S152010","article-title":"Biosynthesized silver and gold nanoparticles are potent antimycotics against opportunistic pathogenic yeasts and dermatophytes","volume":"13","author":"R\u00f3nav\u00e1ri","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.crmicr.2024.100323_bib0084","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jddst.2019.02.017","article-title":"Nanostructured lipid carriers (NLC) system: a novel drug targeting carrier","volume":"51","author":"Salvi","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100323_bib0085","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02183-16","article-title":"Trojan horse transit contributes to blood-brain barrier crossing of a eukaryotic pathogen","volume":"8","author":"Santiago-Tirado","year":"2017","journal-title":"MBio"},{"issue":"1","key":"10.1016\/j.crmicr.2024.100323_bib0086","doi-asserted-by":"crossref","first-page":"15755","DOI":"10.1038\/s41598-023-41994-6","article-title":"First report of environmental isolation of cryptococcus and cryptococcus-like yeasts from Boyac\u00e1, Colombia","volume":"13","author":"Serna-Espinosa","year":"2023","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.crmicr.2024.100323_bib0087","doi-asserted-by":"crossref","DOI":"10.3390\/scipharm87030017","article-title":"Nanoemulsion: a review on mechanisms for the transdermal delivery of hydrophobic and hydrophilic drugs","volume":"87","author":"Shaker","year":"2019","journal-title":"Sci. Pharm."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100323_bib0088","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jconrel.2010.06.018","article-title":"Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain","volume":"147","author":"Shao","year":"2010","journal-title":"J. Controlled Release Official J. Controlled Release Soc."},{"key":"10.1016\/j.crmicr.2024.100323_bib0089","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.628157","article-title":"Beneficial and detrimental effects of reactive oxygen species on lifespan: a comprehensive review of comparative and experimental studies","volume":"9","author":"Shields","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.crmicr.2024.100323_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0265739","article-title":"The aetiology and clinical characteristics of cryptococcal infections in Far North Queensland, tropical Australia","author":"Sim","year":"2022","journal-title":"PLOS ONE"},{"issue":"24","key":"10.1016\/j.crmicr.2024.100323_bib0090","doi-asserted-by":"crossref","DOI":"10.3390\/nano12244470","article-title":"Mechanisms of antifungal properties of metal nanoparticles","volume":"12","author":"Slavin","year":"2022","journal-title":"Nanomaterials (Basel)"},{"issue":"4","key":"10.1016\/j.crmicr.2024.100323_bib0091","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1111\/bcp.14957","article-title":"A case of acute pancreatitis induced by voriconazole during treatment of cryptococcal meningitis","volume":"88","author":"Song","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.crmicr.2024.100323_bib0092","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8040613","article-title":"New approaches for cryptococcosis treatment","volume":"8","author":"Spadari","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.crmicr.2024.100323_bib0093","first-page":"723","article-title":"Drought stress amelioration in plants using green synthesised iron oxide nanoparticles","volume":"41","author":"Sreelakshmi","year":"2021","journal-title":"Mater. Today: Proc."},{"issue":"4","key":"10.1016\/j.crmicr.2024.100323_bib0094","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","article-title":"Liposomal amphotericin B (AmBisome\u00ae): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions","volume":"76","author":"Stone","year":"2016","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.crmicr.2024.100323_bib0095","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7705\/biomedica.6519","article-title":"Gene expression profiles of ERG11, MDR1 and AFR1 in Cryptococcus neoformans var.grubbi from HIV patients","volume":"42","author":"Torres","year":"2022","journal-title":"Biomedica : Revista Del Instituto Nacional de Salud"},{"issue":"1","key":"10.1016\/j.crmicr.2024.100323_bib0096","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41572-023-00472-z","article-title":"Cryptococcal meningitis","volume":"9","author":"Tugume","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.crmicr.2024.100323_bib0097","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-nucl-102419-033642","article-title":"The trojan horse method: a nuclear physics tool for astrophysics","volume":"71","author":"Tumino","year":"2021","journal-title":"Ann. Rev. Nucl. Part. Sci."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100323_bib0098","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s13369-020-04655-8","article-title":"Carboxymethyl cellulose-based hydrogel: dielectric study, antimicrobial activity and biocompatibility","volume":"46","author":"Turky","year":"2021","journal-title":"Arab. J. Sci. Eng."},{"issue":"13","key":"10.1016\/j.crmicr.2024.100323_bib0099","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1039\/D1CS00659B","article-title":"Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?","volume":"51","author":"Vallet-Reg\u00ed","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"6","key":"10.1016\/j.crmicr.2024.100323_bib0100","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1128\/AAC.48.6.2014-2020.2004","article-title":"Effects of voriconazole on cryptococcus neoformans","volume":"48","author":"van Duin","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.crmicr.2024.100323_bib0101","first-page":"15","article-title":"Solid lipid nanoparticles vs. nanostructured lipid carriers: a comparative review","author":"Viegas","year":"2023","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.crmicr.2024.100323_bib0102","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/EC.00039-10","article-title":"Cryptococcal interactions with the host immune system","volume":"9","author":"Voelz","year":"2010","journal-title":"Eukaryotic Cell"},{"issue":"10","key":"10.1016\/j.crmicr.2024.100323_bib0103","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1016\/j.biomaterials.2009.12.042","article-title":"The efficacy of self-assembled cationic antimicrobial peptide nanoparticles against Cryptococcus neoformans for the treatment of meningitis","volume":"31","author":"Wang","year":"2010","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.crmicr.2024.100323_bib0104","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1248\/bpb.34.1129","article-title":"Poly(amidoamine) dendrimers increase antifungal activity of clotrimazole","volume":"34","author":"Winnicka","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.crmicr.2024.100323_bib0105","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2147\/IJN.S17503","article-title":"Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice","volume":"6","author":"Xu","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.crmicr.2024.100323_bib0106","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113955","article-title":"Broadening antifungal spectrum and improving metabolic stablity based on a scaffold strategy: design, synthesis, and evaluation of novel 4-phenyl-4,5-dihydrooxazole derivatives as potent fungistatic and fungicidal reagents","volume":"227","author":"Yin","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.crmicr.2024.100323_bib0107","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1128\/EC.00218-13","article-title":"Stress signaling pathways for the pathogenicity of cryptococcus","volume":"12","author":"Yong-Sun","year":"2013","journal-title":"Eukaryotic Cell"},{"issue":"6","key":"10.1016\/j.crmicr.2024.100323_bib0108","article-title":"Pd@Ag nanosheets in combination with amphotericin B exert a potent anti-cryptococcal fungicidal effect","volume":"11","author":"Zhang","year":"2016","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.crmicr.2024.100323_bib0109","doi-asserted-by":"crossref","first-page":"myac009","DOI":"10.1093\/mmy\/myac009","article-title":"Comparative evaluation of Sensititre YeastOne and VITEK 2 against the Clinical and Laboratory Standards Institute M27-E4 reference broth microdilution method for the antifungal susceptibility testing of Cryptococcus neoformans and Cryptococcus gattii","volume":"60","author":"Zhang","year":"2022","journal-title":"Med. Mycol."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100323_bib0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/myc.13528","article-title":"Induction therapy with high-dose fluconazole plus flucytosine for human immunodeficiency virus-uninfected cryptococcal meningitis patients: feasible or not?","volume":"66","author":"Zhao","year":"2023","journal-title":"Mycoses"},{"issue":"1","key":"10.1016\/j.crmicr.2024.100323_bib0111","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-022-07665-z","article-title":"Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China","volume":"22","author":"Zhao","year":"2022","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100323_bib0112","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40249-023-01073-4","article-title":"Cryptococcus neoformans, a global threat to human health","volume":"12","author":"Zhao","year":"2023","journal-title":"Infect. Dis. Poverty"},{"issue":"1","key":"10.1016\/j.crmicr.2024.100323_bib0113","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40249-023-01073-4","article-title":"Cryptococcus neoformans, a global threat to human health","volume":"12","author":"Zhao","year":"2023","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.crmicr.2024.100323_bib0114","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.655327","article-title":"Voriconazole induced hallucinations and visual disturbances in a female child: a case report and literature review","volume":"9","author":"Zheng","year":"2021","journal-title":"Front. Pediatr."}],"container-title":["Current Research in Microbial Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666517424001068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666517424001068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T21:52:52Z","timestamp":1762638772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666517424001068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":114,"alternative-id":["S2666517424001068"],"URL":"https:\/\/doi.org\/10.1016\/j.crmicr.2024.100323","relation":{},"ISSN":["2666-5174"],"issn-type":[{"value":"2666-5174","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing cryptococcal treatment: The role of nanoparticles in mitigating antifungal resistance","name":"articletitle","label":"Article Title"},{"value":"Current Research in Microbial Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crmicr.2024.100323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100323"}}